NOV-2018 : Bernard Vrijens, CEO of AARDEX, is an invited speaker at the 2nd value added medicines conference, Brussels, November 21, 2018
This event is organized by Medicines for Europe about ” an innovative approach for patients’ future”.

NOV-2018 : Bernard Vrijens, CEO of AARDEX, is an invited speaker at the 2nd value added medicines conference, Brussels, November 21, 2018
This event is organized by Medicines for Europe about ” an innovative approach for patients’ future”.
You’ll often hear the terms “adherence” and “compliance” used as if they mean the same thing. But in healthcare and clinical research, they carry very different meanings. Understanding that difference can change the way we work with patients, design better
Liège, Belgium and Manchester, UK; August 2025: AARDEX Group, a global leader in digital medication adherence solutions, and Pill Connect, a pioneer in connected dispensing technology, have announced a strategic partnership to support a multi-cohort Phase 2A dose selection trial.